These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36779015)

  • 1. APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice.
    Baltissen D; Bold CS; Rehra L; Banićević M; Fricke J; Just J; Ludewig S; Buchholz CJ; Korte M; Müller UC
    Front Cell Neurosci; 2023; 17():1106176. PubMed ID: 36779015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APPsα Rescues Tau-Induced Synaptic Pathology.
    Bold CS; Baltissen D; Ludewig S; Back MK; Just J; Kilian L; Erdinger S; Banicevic M; Rehra L; Almouhanna F; Nigri M; Wolfer DP; Spilger R; Rohr K; Kann O; Buchholz CJ; von Engelhardt J; Korte M; Müller UC
    J Neurosci; 2022 Jul; 42(29):5782-5802. PubMed ID: 35667850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.
    Kacířová M; Železná B; Blažková M; Holubová M; Popelová A; Kuneš J; Šedivá B; Maletínská L
    J Neuroinflammation; 2021 Jun; 18(1):141. PubMed ID: 34158075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.
    Shukla V; Seo J; Binukumar BK; Amin ND; Reddy P; Grant P; Kuntz S; Kesavapany S; Steiner J; Mishra SK; Tsai LH; Pant HC
    J Alzheimers Dis; 2017; 56(1):335-349. PubMed ID: 28085018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
    Crespo-Biel N; Canudas AM; Camins A; Pallàs M
    Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer's Disease Rats Abrogating Aβ
    Das TK; Jana P; Chakrabarti SK; Abdul Hamid MRW
    J Alzheimers Dis Rep; 2019 Aug; 3(1):257-267. PubMed ID: 31754658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.
    Davtyan H; Chen WW; Zagorski K; Davis J; Petrushina I; Kazarian K; Cribbs DH; Agadjanyan MG; Blurton-Jones M; Ghochikyan A
    Vaccine; 2017 Apr; 35(16):2015-2024. PubMed ID: 28320590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576.
    Otth C; Concha II; Arendt T; Stieler J; Schliebs R; González-Billault C; Maccioni RB
    J Alzheimers Dis; 2002 Oct; 4(5):417-30. PubMed ID: 12446973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Desmercières J; Troquier L; Brouillette J; Tsambou L; Grosjean ME; Caillierez R; Demeyer D; Hamdane M; Schindowski K; Blum D; Buée L
    Curr Alzheimer Res; 2011 Sep; 8(6):633-8. PubMed ID: 21605043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.